Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

YTEN - YIELD10 BIOSCIENCE, INC.


Previous close
2.91
2.910   100.000%

Share volume: 0
Last Updated: Wed 15 May 2024 08:02:02 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 4.47%

PREVIOUS CLOSE
CHG
CHG%

N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
9%
Profitability 0%
Dept financing 12%
Liquidity 67%
Performance 2%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
-6.29%
6 Months
-29.71%
1 Year
323.69%
2 Year
-47.89%
Key data
Stock price
$2.91
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
-$24.93
52 WEEK RANGE
$0.24 - $17.26
52 WEEK CHANGE
$297.33
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
657.160 K
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Oliver P. Peoples
Region: US
Website: yield10bio.com
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Yield10 Bioscience, Inc. engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG.

Recent news